Post-Transplant Cardiovascular Disease in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes in the Era of Modern Immunosuppression

被引:3
|
作者
Chukwu, Chukwuma Austin [1 ,2 ]
Rao, Anirudh [1 ,3 ]
Middleton, Rachel [1 ,2 ]
Kalra, Philip A. [1 ,2 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester M13 9PL, England
[2] Northern Care Alliance NHS Fdn Trust, Salford Royal Hosp, Dept Nephrol, Salford M6 8HD, England
[3] Liverpool Hosp NHS Fdn Trust, Royal Liverpool Hosp, Dept Nephrol, Liverpool L7 8YE, England
关键词
kidney transplantation; post-transplant cardiovascular disease; allograft survival; GRAFT;
D O I
10.3390/jcm13102734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Post-transplant cardiovascular disease (PTCVD) poses a significant challenge in kidney transplantation, potentially impacting graft outcomes and patient survival. This retrospective study aimed to investigate the incidence, risk factors, and consequential impact of PTCVD in kidney transplant recipients (KTRs) devoid of pre-existing cardiovascular disease (CVD). Method: The cohort comprised 1114 KTRs, with 749 individuals included after excluding those with pre-existing CVD and early graft loss. PTCVD encompasses ischemic heart disease, myocardial infarction, arrhythmias, heart failure, stroke, peripheral vascular disease, and valvular heart disease. Competing risk regression analysis was performed to identify predictors of PTCVD, while Cox proportional hazards analysis assessed the impact of PTCVD on graft and recipient survival. Results: The cumulative incidence of PTCVD at 5, 10, and 20 years was 5.4%, 14.3%, and 22.5%, respectively. Competing risk regression identified increased age (sub-hazard ratio [SHR], 1.22; p = 0.036) per decade, duration of dialysis (SHR, 1.07; p = 0.048) per year on dialysis, and the slope of the estimated glomerular filtration rate (SHR, 1.08; p = 0.008) mL/min/year decline as independent predictors of higher-risk PTCVD. A higher baseline estimated glomerular filtration rate (eGFR) was protective (SHR, 0.98; p = 0.032). PTCVD was not significantly associated with death-censored graft loss (adjusted hazard ratio [aHR] 1.31; p = 0.48) but was correlated with higher all-cause graft loss (aHR, 1.71; p = 0.011) and recipient mortality (aHR, 1.97; p = 0.004). Conclusion: This study provides insights into PTCVD predictors. Although not directly associated with graft loss, PTCVD significantly correlates with heightened mortality in kidney transplant recipients, emphasizing the need for enhanced clinical management and surveillance strategies.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Cardiovascular risk factors in kidney transplant recipients who develop post-transplant hyperglycemia
    Cosio, FG
    Textor, SC
    Kudva, Y
    Griffin, MD
    Larson, TS
    Stegall, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 409 - 409
  • [2] Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients
    Libertiny, G
    Watson, CJE
    Gray, DWR
    Welsh, KI
    Morris, PJ
    BRITISH JOURNAL OF SURGERY, 2001, 88 (10) : 1330 - 1334
  • [3] Surgical site complications in kidney transplant recipients: incidence, risk factors and outcomes in the modern era
    Wong, Rebecca Bic Kay
    Minkovich, Michelle
    Famure, Olusegun
    Li, Yanhong
    Lee, Jason Young
    Selzner, Markus
    Kim, S. Joseph
    Ghanekar, Anand
    CANADIAN JOURNAL OF SURGERY, 2021, 64 (06) : E669 - E676
  • [4] Incidence, Risk Factors, and Kidney Transplant Outcomes Associated with Post-Transplant Diabetes Mellitus
    Malik, R. F.
    Jia, Y.
    Mansour, S. G.
    Hall, I. E.
    Doshi, M. D.
    Reese, P. P.
    Singh, P.
    Harhay, M. N.
    Weng, F. L.
    Philbrook, H. Thiessen
    Schroppel, B.
    Muthukumar, T.
    Bromberg, J. S.
    Akalin, E.
    Mohan, S.
    Parikh, C. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1010 - 1010
  • [5] Risk of post-transplant malignancy in pediatric kidney transplant recipients is not influenced by induction immunosuppression
    Charnaya, Olga
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [6] Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients
    Bustami, RT
    Ojo, AO
    Wolfe, RA
    Merion, RM
    Bennett, WM
    McDiarmid, SV
    Leichtman, AB
    Held, PJ
    Port, FK
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) : 87 - 93
  • [7] ASSESSING RISK FACTORS OF NON-ADHERENCE AND POST-TRANSPLANT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS
    Maksyutynska, Kateryna
    Batoy, Benedict
    Shafei, Oswa
    Wei, Xinyu
    Famure, Olusegun
    Li, Yanhong
    Kim, Joseph
    TRANSPLANT INTERNATIONAL, 2021, 34 : 114 - 114
  • [8] Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients
    Opelz, Gerhard
    Unterrainer, Christian
    Suesal, Caner
    Doehler, Bernd
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (08) : 1360 - 1367
  • [9] Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?
    Maestro de la Calle, Guillermo
    Fernandez-Ruiz, Mario
    Lopez-Medrano, Francisco
    Polanco, Natalia
    Gonzalez, Esther
    San Juan, Rafael
    Ruiz-Merlo, Tamara
    Origuen, Julia
    Paz-Artal, Estela
    Andres, Amado
    Maria Aguado, Jose
    ATHEROSCLEROSIS, 2018, 269 : 204 - 210
  • [10] Post-transplant hyperglycemia, an underestimated cardiovascular risk factor in kidney transplant recipients
    Cosio, FG
    Kudva, Y
    Textor, SC
    Griffin, MD
    Larson, TS
    Stegall, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 410 - 410